What We're Reading: Page 277
Industry reads hand-picked by our editors
Jun 29, 2018
Jun 28, 2018
-
Washington Examiner
Trump administration plays regulatory hardball in drug-price talks
-
Reuters
Takeda shareholders bin proposal from anti-Shire group
-
BioCentury
Broader CFIUS jurisdiction may have implications for biotech
-
FiveThirtyEight
A Flawed Statistical Method Was Just Banned From A Major Sports Science Journal
Jun 27, 2018
-
Bloomberg
Drugmaker Backs Off Plan to Charge for Unproven ALS Therapy
-
Forbes
The FDA's Infection
-
Financial Times
Takeda chief seeks to allay £46bn Shire bid concerns
Jun 26, 2018
Jun 25, 2018
Jun 22, 2018
-
The Wall Street Journal
What is ailing the drug industry?
-
CNBC
GoodRx, a service for finding the best price on prescription drugs, is in sale talks for up to $3 billion
-
The New York Times
A common virus may play role in Alzheimer's disease, study finds
-
Time
There’s hope for a vaccine to prevent Type 1 diabetes
Jun 21, 2018
-
Bloomberg
The 'Right to Try' Could Cost Dying Patients a Fortune
-
The New York Times
How the Government Can Lower Drug Prices
-
Nikkei Asian Review
Takeda chief's gamble of a lifetime shakes drugmaker to the core
-
Reuters
How U.S. tax reform rewards companies that shift profit to tax havens
Previous
